Related Experiment Video
Updated: Jan 22, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Prostacyclin Analogue-Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
Shin Yajima1, Shigeru Miyagawa1, Satsuki Fukushima1
1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Intravenously injected ONO-1301 nanoparticles selectively target heart injury, reducing infarct size and improving blood flow. This drug delivery method enhances therapeutic effects for myocardial ischemia/reperfusion injury.
Area of Science:
- Cardiovascular Research
- Nanomedicine
- Pharmacology
Background:
- Myocardial ischemia/reperfusion (I/R) injury remains a significant clinical challenge.
- Effective drug delivery to the injured myocardium is crucial for therapeutic intervention.
Purpose of the Study:
- To evaluate the efficacy of ONO-1301-containing nanoparticles (ONO-1301NPs) in treating myocardial I/R injury in a rat model.
- To investigate the targeted accumulation and retention of ONO-1301NPs in the injured heart tissue.
Main Methods:
- Intravenous administration of ONO-1301NPs, ONO-1301 solution, or vehicle in rats subjected to myocardial I/R injury.
- Assessment of nanoparticle distribution, drug retention, infarct size, capillary network preservation, and myocardial blood flow.
- Analysis of proangiogenic and inflammatory cytokine expression in the ischemic myocardium.
Main Results:
- ONO-1301NPs selectively accumulated in the I/R-injured myocardium, with prolonged drug retention compared to ONO-1301 solution.
- Administration of ONO-1301NPs led to up-regulation of proangiogenic cytokines and down-regulation of inflammatory cytokines.
- ONO-1301NP-treated rats showed significantly smaller infarct size, better-preserved capillary networks, and improved myocardial blood flow at 24 hours post-I/R injury.
Conclusions:
- ONO-1301NPs effectively attenuate myocardial I/R injury.
- The therapeutic benefits are mediated through the proangiogenic and anti-inflammatory actions of ONO-1301 delivered via nanoparticles.
- Targeted nanoparticle delivery enhances drug efficacy for myocardial I/R injury treatment.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Impact Loading
In cases of elastic deformation,...
Eccentric Loading
Distributed Loads
For example, consider a bookshelf filled with books stacked vertically adjacent to each other. The weight of the books is evenly distributed over the length of the shelf. As a result, the pressure at different locations on the surface of the...
Stress: General Loading Conditions
The shearing force, possessing potential directionality within the plane of the section, is simplified into two component forces running parallel to the x and y axes....

